Your browser doesn't support javascript.
loading
ASCOT ADAPT study of COVID-19 therapeutics in hospitalised patients: an international multicentre adaptive platform trial.
Denholm, Justin T; Venkatesh, Balasubramanian; Davis, Joshua; Bowen, Asha C; Hammond, Naomi E; Jha, Vivekanand; McPhee, Grace; McQuilten, Zoe; O'Sullivan, Matthew V N; Paterson, David; Price, David; Rees, Megan; Roberts, Jason; Jones, Mark; Totterdell, James; Snelling, Thomas; Trask, Nanette; Morpeth, Susan; Tong, Steven Yc.
  • Denholm JT; Victorian Infectious Diseases Service, The Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Venkatesh B; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, 3000, Australia.
  • Davis J; The George Institute for Global Health, Sydney, Australia.
  • Bowen AC; The George Institute for Global Health, New Delhi, India.
  • Hammond NE; Faculty of Medicine, University of New South Wales, Sydney, Australia.
  • Jha V; Menzies School of Health Research, Charles Darwin University, Darwin, Australia.
  • McPhee G; Department of Infectious Diseases, John Hunter Hospital, Newcastle, NSW, Australia.
  • McQuilten Z; Menzies School of Health Research, Charles Darwin University, Darwin, Australia.
  • O'Sullivan MVN; Department of Infectious Diseases, Perth Children's Hospital, Perth, Australia.
  • Paterson D; Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Australia.
  • Price D; The George Institute for Global Health, Sydney, Australia.
  • Rees M; Faculty of Medicine, University of New South Wales, Sydney, Australia.
  • Roberts J; The George Institute for Global Health, New Delhi, India.
  • Jones M; Faculty of Medicine, University of New South Wales, Sydney, Australia.
  • Totterdell J; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, 3000, Australia.
  • Snelling T; Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), Monash University, Melbourne, Australia.
  • Trask N; Transfusion Research Unit, Monash University, Melbourne, Australia.
  • Morpeth S; Department of Infectious Diseases Westmead Hospital, Westmead, Australia.
  • Tong SY; NSW Health Pathology, Institute for Clinical Pathology and Medical Research, Westmead, Australia.
Trials ; 23(1): 1014, 2022 Dec 14.
Article en En | MEDLINE | ID: mdl-36514143
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Humans País como asunto: Oceania Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Humans País como asunto: Oceania Idioma: En Año: 2022 Tipo del documento: Article